Q1 2027 Jyothy Labs Ltd Earnings Call Transcript
Key Points
- Fabric Care segment delivered strong growth with over 14% value and 10% volume growth, driven by double-digit growth in detergent powders and high growth in liquid detergents.
- Modern trade, e-commerce, and quick commerce channels continued strong momentum, growing at 25-30% and becoming key drivers for premium product adoption.
- The newly launched bio-enzyme-based Exo liquid dishwash has shown encouraging early progress, with the broader Exo franchise growing in mid-to-high single digits in value and double digits in volume.
- The company maintains a strong balance sheet with approximately INR 850 crore in net cash, providing financial flexibility for strategic initiatives and potential M&A.
- Management is focused on cost optimization, supply chain efficiencies, and value engineering, with plans to step up A&P investments to support long-term sustainable growth.
- The company is actively working on diversifying away from crude-linked raw materials and developing new high-margin products, including potential entries into new categories like beauty and personal care.
- Gross margin declined sharply by 950 basis points year-on-year to 38.5%, and EBITDA margin fell by 820 basis points to 8.4%, due to abnormally high input cost inflation and insufficient price increases.
- Urban demand remained subdued, with cautious consumer sentiment and higher household expenses pressuring discretionary spending, leading to muted general trade growth.
- The exit of the Pril brand (effective May 31, 2026) negatively impacted the dishwash portfolio, and the company faces uncertainty regarding potential re-entry by Henkel, with the matter now before the court.
- Personal care segment performance was subdued due to price increases and transient supply chain disruptions, with emerging input cost pressures from rising soap noodle prices.
- Raw material and packaging costs are unlikely to correct immediately, with higher-cost inventory flowing through Q2, and margin recovery is expected to be gradual, with H2 FY2027 expected to be better than H1 but still under pressure.
- The company's heavy dependence on crude-linked inputs (90% of business) makes it vulnerable to commodity volatility, and competitive pricing actions have limited the ability to fully pass on cost increases.
Ladies and gentlemen, good day, and welcome to Jyothy Labs' Q1 FY 2027 earnings conference call hosted by ICICI Securities. (Operator Instructions) Please note that this conference is being recorded.
I now hand the conference over to Mr. Aniket Kamble from ICICI Securities. Thank you, and over to you, sir.
Thank you, Yusuf. Hi. It's an absolute pleasure from ICICI Securities to host the Q1 FY 2027 earnings call for Jyothy Labs. From the management, we have Ms. Jyothy, Chairperson and Managing Director, and Mr. Pawan Agarwal, CFO.
I now hand over the call to Jyothy ma'am for her opening remarks. Thank you, and over to you, ma'am.
Good afternoon, everyone, and a warm welcome to the Q1 FY 2027 earnings of Jyothy Labs Limited. Our financial results and investor presentation are available on our website and the stock exchanges. I trust you have had the opportunity to review
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
